Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Trufan SJ"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fasola CE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC., Graham E; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC., Sha W; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC., Schepel CR; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC., Trufan SJ; Department of Biostatistics and Data Sciences, Levine Cancer Institute, Atrium Health, Charlotte, NC., Hecksher A; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC., White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC., Hadzikadic-Gusic L; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC. Electronic address: Lejla.Hadzikadic-Gusic@atriumhealth.org.
Publikováno v:
Clinical breast cancer [Clin Breast Cancer] 2024 Jul; Vol. 24 (5), pp. e396-e407.e4. Date of Electronic Publication: 2024 Feb 28.
Autor:
Fasola CE; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Sharp HJ; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Clavin NW; Division of Plastic and Reconstructive Surgery, Atrium Health, Charlotte, NC, USA., Sha W; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Schepel CR; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Trufan SJ; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Graham E; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Hecksher A; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., White RL Jr; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Hadzikadic-Gusic L; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. lejla.hadzikadic-gusic@atriumhealth.org.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Dec; Vol. 30 (13), pp. 8362-8370. Date of Electronic Publication: 2023 Aug 21.
Autor:
White RL Jr; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Wallander ML; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Leighliter ME; Breast Clinic, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Sha W; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Palmer PP; Division of Community and Social Impact, Atrium Health, Charlotte, North Carolina, USA., Sejdic A; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Benbow JH; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Sarma D; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Robinson MM; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Trufan SJ; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA., Sarantou T; Division of Surgical Oncology, Department of Surgery, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Publikováno v:
Cancer [Cancer] 2023 Oct 15; Vol. 129 (20), pp. 3230-3238. Date of Electronic Publication: 2023 Jun 29.
Autor:
Shahid Z; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Patrick AL; LCI Clinical Research, Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Wallander ML; LCI Clinical Research, Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Donahue EE; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Trufan SJ; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Tan AR; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Hwang JJ; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Burgess EF; Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Ragon B; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Ghosh N; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Grunwald MR; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Voorhees PM; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Copelan EA; Department of Hematologic Malignancies and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, United States., Raghavan D; Levine Cancer Institute, Atrium Health, Charlotte, NC, United States.
Publikováno v:
Vaccine: X [Vaccine X] 2023 Aug; Vol. 14, pp. 100289. Date of Electronic Publication: 2023 Mar 30.
Autor:
Squires MH; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Donahue EE; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Wallander ML; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Trufan SJ; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Shea RE; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Lindholm NF; Department of Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Hill JS; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA., Salo JC; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC 28204, USA.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Feb 18; Vol. 30 (2), pp. 2482-2492. Date of Electronic Publication: 2023 Feb 18.
Autor:
Lavery L; Department of Pharmacy, Levine Cancer Institute, Atrium Health, 10660 Park Rd, Charlotte, NC, 28210, USA. lesli.lavery@atriumhealth.org., DiSogra K; Specialty Pharmacy Service, Atrium Health, 4400 Golf Acres Drive, Charlotte, NC, 28208, USA., Lea J; Department of Pharmacy, Levine Cancer Institute, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA., Trufan SJ; Department of Biostatistics, Levine Cancer Institute, Atrium Health, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA., Symanowski JT; Department of Biostatistics, Levine Cancer Institute, Atrium Health, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA., Roberts A; Specialty Pharmacy Service, Atrium Health, 4400 Golf Acres Drive, Charlotte, NC, 28208, USA., Moore DC; Department of Pharmacy, Levine Cancer Institute, 100 Medical Park Drive, Concord, NC, 28025, USA., Heeke A; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USA., Pal S; Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, 10660 Park Rd, Charlotte, NC, 28210, USA.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Dec; Vol. 30 (12), pp. 9803-9809. Date of Electronic Publication: 2022 Oct 19.
Autor:
Frenkel CH; Division of Head and Neck Surgical Oncology, Department of Surgery Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Brickman DS; Division of Head and Neck Surgical Oncology, Department of Surgery Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Trufan SJ; Department of Biostatistics Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Ward MC; Department of Radiation Oncology Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Moeller BJ; Department of Radiation Oncology Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Carrizosa DR; Department of Medical Oncology Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Sumrall AL; Department of Medical Oncology Levine Cancer Institute, Atrium Health Charlotte North Carolina USA., Milas ZL; Division of Head and Neck Surgical Oncology, Department of Surgery Levine Cancer Institute, Atrium Health Charlotte North Carolina USA.
Publikováno v:
Laryngoscope investigative otolaryngology [Laryngoscope Investig Otolaryngol] 2022 Nov 16; Vol. 7 (6), pp. 1849-1856. Date of Electronic Publication: 2022 Nov 16 (Print Publication: 2022).
Autor:
Milas ZL; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A.; Zvonimir.Milas@atriumhealth.org., Neelands B; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Trufan SJ; Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Benbow J; Clinical Trials Office, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Carrizosa D; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Brickman DS; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Frenkel CH; Division of Surgical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Sumrall AL; Department of Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Sudhakar SM; Department of Endocrinology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A., Ward MC; Department of Radiation Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, U.S.A.
Publikováno v:
Anticancer research [Anticancer Res] 2022 Sep; Vol. 42 (9), pp. 4429-4437.